Evidano home
Commentary on News

AI Qualitative Analysis of Hepatitis C Access

Evidano9 min read

Public health researchers need to understand why people diagnosed with hepatitis C do not begin or complete treatment, but the answer often sits across program data, interview transcripts, language differences, and healthcare experiences. AI qualitative analysis of hepatitis C treatment access can help research teams organize these materials into defensible themes without reducing patient stories to percentages. Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended surveys, and public health documents. The November 20, 2026 PLoS One study from Los Angeles County provides a useful example: quantitative data showed how frequently barriers occurred, while interviews explained why cost, language, transportation, provider delays, and limited treatment knowledge affected care. This article summarizes the study and translates its mixed-methods design into a practical workflow for public health, healthcare, and qualitative research teams.

Key Takeaways

The Exploring barriers and facilitators to Hepatitis C virus treatment access in Los Angeles County: A mixed-methods study, published on November 20, 2026, found that hepatitis C treatment access was limited by personal, provider, insurance, and healthcare access barriers. The study shows why AI qualitative analysis of hepatitis C treatment access is most useful when thematic findings are interpreted alongside quantitative program data.

  • According to the PLoS One study, researchers examined de-identified data from 344 Los Angeles County case-residents contacted between October 2024 and January 2025.
  • According to the PLoS One study, 54% of case-residents reported barriers, and among the 91 people reporting specific barriers, personal barriers accounted for 43%, provider-related barriers for 31%, insurance barriers for 13%, and inadequate medical access for 13%.
  • According to the PLoS One study, qualitative interviews included 10 participants, including 7 untreated participants and 3 treated participants, and were conducted in English and Spanish.
  • According to the PLoS One study, major qualitative themes included homelessness, incarceration, drug addiction, language barriers, long provider wait times, cost, transportation, limited information, provider trust, and family support.
  • According to the PLoS One study, suggested interventions included language support, patient navigation, care coordination, mobile clinics for people experiencing homelessness, treatment continuity after incarceration, and removal of insurance restrictions.

What the Hepatitis C Access Study Measured

The Los Angeles County study used a convergent parallel mixed-methods design to compare the frequency of reported barriers with the lived experiences behind those barriers. According to the PLoS One study, the quantitative component used descriptive statistics from Project HCV Connect, while the qualitative component used thematic analysis of semi-structured interviews collected during the same period, from October 2024 through January 2025.

According to the PLoS One study, LA County Department of Public Health case managers contacted 344 adults with reported hepatitis C-positive test results. The study recorded treatment status, insurance, demographics, willingness to receive treatment, and reported barriers, while interviews explored knowledge, stigma, healthcare navigation, insurance, and treatment experiences.

The PLoS One research team transcribed interviews verbatim, removed identifying information, and independently coded transcripts before meeting to compare codes and resolve discrepancies. The study used the Health Belief Model to organize concepts such as perceived barriers, treatment benefits, and self-efficacy, while treatment status helped researchers compare untreated and treated participants.

The study authors cautioned that the quantitative analysis was descriptive because most specific barrier categories had sample sizes below 15, and the qualitative sample was small and unevenly distributed. The findings are therefore exploratory and should guide further research rather than serve as population-level causal estimates.

Hepatitis C Treatment Access Findings Snapshot

Date or study periodMetricValueImplication for qualitative research
October 2024 to January 2025Case-residents contacted344A mixed-methods dataset can connect program-scale patterns with individual narratives, according to the PLoS One study.
October 2024 to January 2025Case-residents already treated168, or 49%Treatment status supports cross-segment comparison between treated and untreated experiences, according to the PLoS One study.
October 2024 to January 2025Case-residents not treated176Untreated participants help researchers investigate delayed or missed treatment journeys, according to the PLoS One study.
October 2024 to January 2025Case-residents reporting barriers54%Barrier prevalence identifies the scale of the access problem before interview themes explain its causes, according to the PLoS One study.
November 20, 2026 publicationInterview participants10, including 7 untreated and 3 treatedSmall interview samples can provide context, but findings require cautious interpretation, according to the PLoS One study.
2019 to 2023People diagnosed with hepatitis C in Los Angeles County27, 678The broader diagnosis count shows why local linkage-to-care research matters, according to the PLoS One study.
2019 to 2023People reporting knowledge of hepatitis C treatment30%Limited treatment knowledge is a relevant topic for interview guides and patient education analysis, according to the PLoS One study.
2019 to 2023People completing hepatitis C treatment32%Completion data indicate that access research must examine both treatment initiation and continuity, according to the PLoS One study.

Implications for AI Qualitative Analysis of Hepatitis C Access

Why should researchers analyze barriers by segment?

Researchers should analyze hepatitis C treatment barriers by treatment status, language, insurance, and relevant social circumstances because the PLoS One study found that different groups described different obstacles.

Untreated participants described cost, language barriers, transportation, limited information, and difficulty navigating the healthcare system. Treated participants described homelessness, incarceration, drug addiction, and long waits for specialist care, according to the PLoS One study.

An AI-assisted workflow can organize codes such as cost, language support, provider trust, transportation, stigma, and family support, then compare their presence across participant segments. Human researchers should review quotations and contextual meaning before drawing conclusions.

How can interview quotations improve public health decisions?

Interview quotations can show how an access barrier operates in practice, which helps public health teams design more specific interventions. One untreated Spanish-speaking participant told the PLoS One researchers, “Since I don’t speak 100% English... I didn’t understand anything, ” linking language access to withdrawal from care.

A second untreated participant said, “I hadn’t heard so much about [HCV at the time of my diagnosis], ” according to the PLoS One study. The quotation supports a research focus on treatment knowledge, patient education, and communication quality rather than treating delayed care as a simple matter of individual motivation.

What should public health teams do with these findings?

Public health teams should test interventions that address both individual understanding and healthcare-system friction. The PLoS One authors specifically identified language support, culturally tailored education, patient navigation, care coordination, mobile clinics, continuity after incarceration, and fewer insurance restrictions as potential strategies.

Researchers can use AI qualitative analysis to monitor whether new interviews show changes in barrier themes over time. The analysis should preserve negative cases, differences between treated and untreated participants, and the original language or translation context.

How Evidano Helps With Hepatitis C Qualitative Analysis

Problem: Interview synthesis is slow across languages

Evidano is an AI-powered qualitative data analysis platform that ingests interview transcripts, research papers, reports, news, blogs, and survey spreadsheets for thematic, content, frequency, and cross-segment analysis.

For studies like the Los Angeles County research, teams can use transcription and translation workflows to prepare English- and Spanish-language interviews, then compare themes such as language barriers, treatment knowledge, cost, and provider trust. Researchers can review the source material and retain human control over interpretation. Learn more about Evidano's qualitative research features.

Problem: Findings need comparison across participant groups

Evidano can support cross-segment analysis across variables such as treated versus untreated participants, language, insurance, or recruitment source. Researchers can inspect frequencies, code hierarchies, and co-occurrence patterns to identify which barriers appear together.

The PLoS One study connected quantitative barrier categories with qualitative explanations. A similar workflow in Evidano can help teams move from a broad code such as provider-related barriers to subcodes such as language difficulty, long wait times, incomplete follow-up, and poor care coordination.

Problem: Researchers need answers without losing the evidence trail

Evidano's AI chat can help researchers ask focused questions across uploaded documents and analyses, such as which participants mentioned transportation or how treated participants described provider trust. Researchers should verify generated answers against the underlying transcript excerpts before publication.

Evidano encrypts data and does not use customer data to train third-party models, according to Evidano's data handling policy. Teams can review Evidano's data security information when evaluating an AI-assisted qualitative research platform for sensitive health research.

FAQ: AI Qualitative Analysis of Hepatitis C Treatment Access

What were the main barriers to hepatitis C treatment in Los Angeles County?

The main barriers were personal, provider-related, insurance, and medical access barriers, according to the PLoS One study published on November 20, 2026.

Among 91 case-residents who reported specific barriers, personal barriers represented 43%, provider-related barriers represented 31%, insurance barriers represented 13%, and inadequate medical access represented 13% during the October 2024 to January 2025 study period.

How many people participated in the qualitative hepatitis C interviews?

Ten people participated in the qualitative interviews, including 7 untreated participants and 3 treated participants, according to the PLoS One study.

The interviews were conducted in English and Spanish and were used to explain the patterns found in data from 344 contacted case-residents.

How can AI help analyze hepatitis C patient interviews?

AI can help researchers organize transcripts into themes, compare segments, identify recurring concepts, and retrieve supporting excerpts, while human researchers remain responsible for interpretation and reporting.

For hepatitis C access research, useful codes may include language barriers, cost, transportation, treatment knowledge, stigma, provider trust, family support, incarceration, and homelessness, all of which appeared in the PLoS One study.

What are the limitations of the Los Angeles County hepatitis C study?

The study was exploratory and had a small qualitative sample, uneven representation between treated and untreated participants, and insufficient subgroup sizes for inferential quantitative analysis, according to the PLoS One authors.

The findings may not generalize to all Los Angeles County residents or capture the experiences of every linguistic minority group. AI analysis does not remove these sampling and study-design limitations.

Is AI qualitative analysis a substitute for public health researchers?

AI qualitative analysis is an aid for organizing and synthesizing evidence, not a substitute for researcher judgment, according to the methodological limits described in the PLoS One study.

Researchers should validate codes, inspect quotations in context, document analytical decisions, protect participant privacy, and avoid presenting exploratory themes as causal findings.

Conclusion and Next Steps for Hepatitis C Research

The Los Angeles County study shows that hepatitis C treatment access is shaped by interacting personal, linguistic, financial, provider, and structural conditions. AI qualitative analysis can help public health teams connect those conditions across interviews, program data, and participant segments, but careful human review remains essential. Evidano gives researchers a practical workspace for thematic analysis, cross-segment comparisons, document chat, and secure handling of sensitive qualitative evidence. Start organizing your next public health research project with Try Evidano for free.

Topics

  • AI qualitative analysis of hepatitis C treatment access
  • qualitative analysis of hepatitis C barriers
  • AI thematic analysis public health research
  • hepatitis C patient interviews

Keep reading

Browse all articles